| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
STANFORD, Calif.—Stanford University researchers are looking to track down gene fusions that can drive cancers proliferation and uncover fusions in individual tumor cells. To do that, they have turned to a single-cell statistical modeling method, and a member of the team presented their method during the Bioinformatics and Artificial Intelligence minisymposium at the AACR Virtual Annual Meeting II in June.
 
In the session, Dr. Roozbeh Dehghannasin, a postdoctoral researcher at the Stanford School of Medicine, described the statistical model designed to detect gene fusions at a single-cell level, explaining that many gene fusions are known to drive cancer development, but limitations in current technologies have hindered fully understanding their functions.
 
The model developed by the Stanford team, which is called SICILIAN, can be integrated into conventional splice alignment tools to detect different RNA variants, such as splice junctions, gene fusions and circular RNA.
 
Dehghannasin said that the team found that SICILIAN detected gene fusions with similar sensitivity but greater specificity than an existing gene fusion detection tool called STAR-Fusion.

Related Topics

Published In

Volume 16 - Issue 8 | September 2020

September 2020

September 2020 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D illustration of two DNA strands in a transparent bubble

Overcoming barriers in gene therapy 

Advanced gene editing, delivery, and analytical tools are driving better gene therapies.
An illustration of the human brain

A multiomic approach to profiling brain tumors

Probing the molecular drivers of brain metastasis reveals novel therapeutic targets.
A 3D illustration of purple-colored cancer cells surrounded by transparent immune cells with yellow nuclei

Enhancing immune cell profiling with digital technologies 

Software innovations help researchers decode immune complexity in cancer.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue